Tetra Bio-Pharma Inc. (TSX:TBP.TO) (OTCQB:TBPMF) Chairman of the Board Bill Cheliak tells Proactive the Ottawa-based group has added two new board members and has appointed a new COO. Cheliak says board members Dale Weil and Dr. Brent Norton, along with COO Dr. Graham Wood will be key to helping to advance many of the firm's clinical assets to commercialization.

Tetra Bio-Pharma adds two experienced life sciences execs to its board, new.COO to management team
Quick facts: Tetra Bio-Pharma
Price: 0.19 CAD
Market: TSX
Market Cap: $53.55 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Tetra Bio-Pharma named herein, including the promotion by the Company of Tetra Bio-Pharma in any Content on the Site, the Company receives from...
FOR OUR FULL DISCLAIMER CLICK HEREDeep dive
